![Joshua Neumiller(@JoshuaNeumiller) 's Twitter Profileg](https://pbs.twimg.com/profile_images/1318235042565419009/ztIDzcLk_200x200.jpg)
Joshua Neumiller
@JoshuaNeumiller
Vice-Chair & Allen I. White Distinguished Professor
College of Pharmacy and Pharmaceutical Sciences
Washington State University
ID:1317983165714112512
https://pharmacy.wsu.edu/directory/joshua-neumiller/ 19-10-2020 00:17:51
490 Tweet
145 Takipçi
154 Takip Edilen
![Prof Kamlesh Khunti(@kamleshkhunti) 's Twitter Profile Photo Prof Kamlesh Khunti(@kamleshkhunti) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/510366368366338048/q9ro2bV__200x200.jpeg)
Timing of Cardio-Kidney Protection With SGLT2 Inhibitor varies in trials
Herat failure benefits occur early
MACE events evident early
Cardiovascular deaths & kidney outcome benefits much later
ahajournals.org/doi/10.1161/CI…
Brendon Neuen Muthu Vaduganathan et al
![Prof Kamlesh Khunti (@kamleshkhunti) on Twitter photo 2024-05-13 07:33:29 Timing of Cardio-Kidney Protection With SGLT2 Inhibitor varies in trials Herat failure benefits occur early MACE events evident early Cardiovascular deaths & kidney outcome benefits much later ahajournals.org/doi/10.1161/CI… @brendonneuen @mvaduganathan et al Timing of Cardio-Kidney Protection With SGLT2 Inhibitor varies in trials Herat failure benefits occur early MACE events evident early Cardiovascular deaths & kidney outcome benefits much later ahajournals.org/doi/10.1161/CI… @brendonneuen @mvaduganathan et al](https://pbs.twimg.com/media/GNcT7eWWsAARQSZ.jpg)
![American Diabetes Association - DiabetesPro(@ADA_DiabetesPro) 's Twitter Profile Photo American Diabetes Association - DiabetesPro(@ADA_DiabetesPro) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1698917209026781184/rPM_3011_200x200.jpg)
![Scott Isaacs(@scottisaacsmd) 's Twitter Profile Photo Scott Isaacs(@scottisaacsmd) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1659541603378245632/tAStpDfR_200x200.jpg)
![BMJ Open Diabetes Research & Care journal(@DiabetesRC) 's Twitter Profile Photo BMJ Open Diabetes Research & Care journal(@DiabetesRC) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/872503194584322048/oqsmsSX3_200x200.jpg)
Circulating metabolomic markers in association with overall burden of microvascular complications in type 1 diabetes Viktor Rotbain Curovic Tarunveer Singh Ahluwalia Peter Rossing Steno Diabetes Center Copenhagen
Read more here 👉 bit.ly/446Op88
![BMJ Open Diabetes Research & Care journal (@DiabetesRC) on Twitter photo 2024-04-23 21:55:06 Circulating metabolomic markers in association with overall burden of microvascular complications in type 1 diabetes @CurovicViktor @tsahluwalia @PeterRossing @Stenodiabetes Read more here 👉 bit.ly/446Op88 Circulating metabolomic markers in association with overall burden of microvascular complications in type 1 diabetes @CurovicViktor @tsahluwalia @PeterRossing @Stenodiabetes Read more here 👉 bit.ly/446Op88](https://pbs.twimg.com/media/GL4Z3vmXcAArvbM.jpg)
![Springer IME(@SpringerIME) 's Twitter Profile Photo Springer IME(@SpringerIME) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/720295541171691520/MfzDfktd_200x200.jpg)
(1/12) Welcome to our Tutorial on recent hot topics in #CGM use in type 2 diabetes #T2D . Follow this thread to learn more from our expert faculty, Dr. Rozalina McCoy Rozalina (Grubina) McCoy, MD MS, Associate Professor and endocrinologist specializing in #diabetes care at University of Maryland.
![Springer IME (@SpringerIME) on Twitter photo 2024-04-24 11:17:15 (1/12) Welcome to our Tutorial on recent hot topics in #CGM use in type 2 diabetes #T2D. Follow this thread to learn more from our expert faculty, Dr. Rozalina McCoy @RozalinaMD, Associate Professor and endocrinologist specializing in #diabetes care at University of Maryland. (1/12) Welcome to our Tutorial on recent hot topics in #CGM use in type 2 diabetes #T2D. Follow this thread to learn more from our expert faculty, Dr. Rozalina McCoy @RozalinaMD, Associate Professor and endocrinologist specializing in #diabetes care at University of Maryland.](https://pbs.twimg.com/media/GL6hGOUXkAAahdA.jpg)
![BMJ Open Diabetes Research & Care journal(@DiabetesRC) 's Twitter Profile Photo BMJ Open Diabetes Research & Care journal(@DiabetesRC) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/872503194584322048/oqsmsSX3_200x200.jpg)
Circulating metabolomic markers in association with overall burden of microvascular complications in type 1 diabetes Viktor Rotbain Curovic Tarunveer Singh Ahluwalia Peter Rossing Steno Diabetes Center Copenhagen
Read more here 👉 bit.ly/446Op88
![BMJ Open Diabetes Research & Care journal (@DiabetesRC) on Twitter photo 2024-04-18 19:00:14 Circulating metabolomic markers in association with overall burden of microvascular complications in type 1 diabetes @CurovicViktor @tsahluwalia @PeterRossing @Stenodiabetes Read more here 👉 bit.ly/446Op88 Circulating metabolomic markers in association with overall burden of microvascular complications in type 1 diabetes @CurovicViktor @tsahluwalia @PeterRossing @Stenodiabetes Read more here 👉 bit.ly/446Op88](https://pbs.twimg.com/media/GLeB5bUXkAAT8D0.jpg)
![American Diabetes Association - DiabetesPro(@ADA_DiabetesPro) 's Twitter Profile Photo American Diabetes Association - DiabetesPro(@ADA_DiabetesPro) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1698917209026781184/rPM_3011_200x200.jpg)
![Joshua Neumiller(@JoshuaNeumiller) 's Twitter Profile Photo Joshua Neumiller(@JoshuaNeumiller) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1318235042565419009/ztIDzcLk_200x200.jpg)
Honored to work with this great group of ADA staff and volunteers on this effort Nuha ElSayed, MD, MMSc george bakris Ian de Boer Dr. Bob Rozalina (Grubina) McCoy, MD MS Connie Rhee
diabetesjournals.org/clinical/artic…
![Brendon Neuen(@brendonneuen) 's Twitter Profile Photo Brendon Neuen(@brendonneuen) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1769816320529379328/Hg1jkPLk_200x200.jpg)
How can we prioritise accelerated therapeutic implementation of the 'four pillars' of GDMT for diabetes & CKD?
-RASi
-SGLT2i
-ns-MRA
-GLP-1RA
Muthu Vaduganathan Katherine Tuttle & I outline what an 'accelerated, risk-based approach' might look like
Circulation ahajournals.org/doi/10.1161/CI…
![Brendon Neuen (@brendonneuen) on Twitter photo 2024-04-15 21:05:24 How can we prioritise accelerated therapeutic implementation of the 'four pillars' of GDMT for diabetes & CKD? -RASi -SGLT2i -ns-MRA -GLP-1RA @mvaduganathan @KatherineTuttl8 & I outline what an 'accelerated, risk-based approach' might look like @CircAHA ahajournals.org/doi/10.1161/CI… How can we prioritise accelerated therapeutic implementation of the 'four pillars' of GDMT for diabetes & CKD? -RASi -SGLT2i -ns-MRA -GLP-1RA @mvaduganathan @KatherineTuttl8 & I outline what an 'accelerated, risk-based approach' might look like @CircAHA ahajournals.org/doi/10.1161/CI…](https://pbs.twimg.com/media/GLPADXSbUAAN-Ts.jpg)
![American Diabetes Association - DiabetesPro(@ADA_DiabetesPro) 's Twitter Profile Photo American Diabetes Association - DiabetesPro(@ADA_DiabetesPro) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1698917209026781184/rPM_3011_200x200.jpg)
![Valerie Luyckx(@valerie_luyckx) 's Twitter Profile Photo Valerie Luyckx(@valerie_luyckx) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1591316871386697732/0BpC4_3D_200x200.jpg)
Powerful bottom line Katherine Tuttle - people with #diabetes must urgently be treated early - prevent deaths, save kidneys, hearts, wellbeing
True expertise - telling it like it is
World Kidney Day World Congress of Nephrology #isnwcn
![Valerie Luyckx (@valerie_luyckx) on Twitter photo 2024-04-14 18:23:34 Powerful bottom line @KatherineTuttl8 - people with #diabetes must urgently be treated early - prevent deaths, save kidneys, hearts, wellbeing True expertise - telling it like it is @worldkidneyday @ISNWCN #isnwcn Powerful bottom line @KatherineTuttl8 - people with #diabetes must urgently be treated early - prevent deaths, save kidneys, hearts, wellbeing True expertise - telling it like it is @worldkidneyday @ISNWCN #isnwcn](https://pbs.twimg.com/media/GLJTJtsXYAAHLGe.jpg)
![Diana Isaacs, PharmD, BC-ADM, CDCES(@DianaMIsaacs) 's Twitter Profile Photo Diana Isaacs, PharmD, BC-ADM, CDCES(@DianaMIsaacs) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1455180990792536066/8giYNAss_200x200.jpg)
![Nuha ElSayed, MD, MMSc(@nuhaaelsayed) 's Twitter Profile Photo Nuha ElSayed, MD, MMSc(@nuhaaelsayed) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1499007333682364422/VRKhPkrX_200x200.jpg)
🤔🩺 Calling all with diabetes! 🤔 Questions about diabetes-related kidney disease?
Check out ADA’s “Guidelines InSight” infographic! 💡💪 Simplifying guidelines. For more infographics, visit: lnkd.in/eHDvG228 📚🔍 Stay informed, empowered! ❤️🤍 #DiabetesAwareness …
![Nuha ElSayed, MD, MMSc (@nuhaaelsayed) on Twitter photo 2024-04-08 11:16:53 🤔🩺 Calling all with diabetes! 🤔 Questions about diabetes-related kidney disease? Check out ADA’s “Guidelines InSight” infographic! 💡💪 Simplifying guidelines. For more infographics, visit: lnkd.in/eHDvG228 📚🔍 Stay informed, empowered! ❤️🤍 #DiabetesAwareness… 🤔🩺 Calling all with diabetes! 🤔 Questions about diabetes-related kidney disease? Check out ADA’s “Guidelines InSight” infographic! 💡💪 Simplifying guidelines. For more infographics, visit: lnkd.in/eHDvG228 📚🔍 Stay informed, empowered! ❤️🤍 #DiabetesAwareness…](https://pbs.twimg.com/media/GKo39rXWcAABQ_a.jpg)
![Nature Cardiovascular Research(@NatureCVR) 's Twitter Profile Photo Nature Cardiovascular Research(@NatureCVR) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1371830121015951370/b1C9e4f1_200x200.jpg)
![Nature Reviews Nephrology(@NatRevNeph) 's Twitter Profile Photo Nature Reviews Nephrology(@NatRevNeph) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1544704761563414532/xfyunu_0_200x200.jpg)
New Review! Combination therapy for kidney disease in people with diabetes by D. van Raalte, Petter Bjornstad, M.D., D. Cherney, I. de Boer, P. Fioretto, D. Gordin, Frederik Persson, Sylvia Rosas,MD,MSCE, Peter Rossing, J. Schaub, Katherine Tuttle, Sushrut Waikar & H. Heerspink go.nature.com/4aB7lh8
![Nature Reviews Nephrology (@NatRevNeph) on Twitter photo 2024-04-04 11:05:48 New Review! Combination therapy for kidney disease in people with diabetes by D. van Raalte, @PBjornstadMD, D. Cherney, I. de Boer, P. Fioretto, D. Gordin, @FrederikPersson, @sylviaerosas, @P_Rossing, J. Schaub, @KatherineTuttl8, @waikarss & H. Heerspink go.nature.com/4aB7lh8 New Review! Combination therapy for kidney disease in people with diabetes by D. van Raalte, @PBjornstadMD, D. Cherney, I. de Boer, P. Fioretto, D. Gordin, @FrederikPersson, @sylviaerosas, @P_Rossing, J. Schaub, @KatherineTuttl8, @waikarss & H. Heerspink go.nature.com/4aB7lh8](https://pbs.twimg.com/media/GKUOvpfWAAA7RM1.png)
![Rodolfo J. Galindo MD(@RodolfoJGalindo) 's Twitter Profile Photo Rodolfo J. Galindo MD(@RodolfoJGalindo) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1398446177738240009/PXMDmw_3_200x200.jpg)
GLP-1RA and SGLT2i may be the preferred glucose-lowering agents for cardiovascular risk reduction in patients at moderate baseline risk for CVD.
Joshua Neumiller Victor Montori, MD 💙 Joshua Neumiller
![Edgar V. Lerma 🇵🇭(@edgarvlermamd) 's Twitter Profile Photo Edgar V. Lerma 🇵🇭(@edgarvlermamd) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1456040662453866506/w0dEp0aZ_200x200.jpg)
![BMJ Open Diabetes Research & Care journal(@DiabetesRC) 's Twitter Profile Photo BMJ Open Diabetes Research & Care journal(@DiabetesRC) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/872503194584322048/oqsmsSX3_200x200.jpg)
Cost-effectiveness analysis of two interventions to promote physical activity in a multiethnic population at high risk of diabetes💲 🏃 Prof Kamlesh Khunti
Learn more from this economic evaluation of the 48-month PROPELS trial
👇
bit.ly/3IVabla
![BMJ Open Diabetes Research & Care journal (@DiabetesRC) on Twitter photo 2024-03-26 21:50:06 Cost-effectiveness analysis of two interventions to promote physical activity in a multiethnic population at high risk of diabetes💲 🏃 @kamleshkhunti Learn more from this economic evaluation of the 48-month PROPELS trial 👇 bit.ly/3IVabla Cost-effectiveness analysis of two interventions to promote physical activity in a multiethnic population at high risk of diabetes💲 🏃 @kamleshkhunti Learn more from this economic evaluation of the 48-month PROPELS trial 👇 bit.ly/3IVabla](https://pbs.twimg.com/media/GJoMNkgXYAAa3hu.jpg)